This study aims to design a patient -centered program to prevent or delay frailty , functional decline and adverse events, and evaluates the effectiveness of the program with a randomized clinical trial.
Objective: To design and evaluate the implementation and impact of a multimodal intervention focused on elderly patients living in the community in preventing or delaying frailty, functional decline and risk of institutionalization, hospitalization and death. Design: Study in two phases: a qualitative study to develop the intervention and a randomized clinical trial with parallel arms and control group. Intervention: Participants in the control group will receive the usual standard care and regular referrals. Patients in the intervention group will be first derived to a nurse case manager for initial application of a comprehensive geriatric assessment (CGA). Then patient-centered interventions will be prescribed, according to the different target areas identified in the geriatric assessment, along with medication review, aerobics exercise plan and memory workshops following the model adapted in Phase I. After 3 and 18 months, measures of functional and cognitive performance, quality of life, frailty, adverse outcomes (institutionalization, hospitalization, death) and health care costs will be collected.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
300
Comprehensive geriatric assessment. Patient-centered interventions according to the different target areas identified in the geriatric assessment. Medication review. Groupal Exercise plan and memory workshops.
IDIAP JGol
Barcelona, Spain
Change from Baseline in Short Physical Performance Battery (SPPB) at 3 and 18 months
The Short Physical Performance Battery (SPPB) is a standardised assessment tool of lower limb function, testing 3 dimensions: standing balance, walking speed, and chair stands. Each component is scored between 0-4, total score from 0 (poor performance) to 12 (best performance).
Time frame: 0, 3, 18 months
Change from Baseline in the Quick Mild Cognitive Impairment Screen (Qmci-S) at 3 and 18 months
The Quick Mild Cognitive Impairment (Qmci) screen is a multi-purpose, short cognitive screening instrument designed to differentiate between normal cognitive function, subjective cognitive disorders, mild cognitive impairment (MCI) and early dementia and to measure change over time.
Time frame: 0, 3, 18 months
Change from Baseline in Health Related Quality of Life (EuroQol 5D) at 3 and 18 months
EuroQol 5D EQ-5D is a standardised measure of health status developed by the EuroQol Group in order to provide a simple, generic measure of health for clinical and economic appraisal.
Time frame: 0, 3, 18 months
Change from Baseline in Functional Capacity at 3 and 18 months
Activities of daily living: Barthel Index and Lawton\&Brody Index
Time frame: 0, 3, 18 months
Change from Baseline in the Risk Instrument for Screening in the Community (RISC) at 3 and 18 months
Risk Instrument for Screening in the Community is a validated short (2-5 min), global subjective assessment of risk created to identify patients' 1-year risk of three outcomes: institutionalization, hospitalization and death.
Time frame: 0, 3, 18 months
Change from Baseline in Clinical Frailty Scale (CFS) at 3 and 18 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
The clinical frailty scale is a 9 points measure of frailty based on clinical judgement.
Time frame: 0,3 18 months
Change from Baseline in the Gerontopole Frailty Screening Tool (GFST) at 3 and 18 months
Gerontopole Frailty Screening Tool is a questionnaire aimed to measure general signs and/or symptoms potentially indicating the presence of an underlying frailty. These questions largely mirror the criteria that are commonly used to operationalize the frailty status.
Time frame: 0,3,18 months